Otonomy to Participate in Two Upcoming Investor Conferences

Rhea-AI Summary

Otonomy, Inc. (Nasdaq: OTIC) announced its participation in two upcoming virtual investor conferences. The Evercore ISI 3rd Annual HealthCONx Conference will take place on December 1, 2020, at 3:05 p.m. ET, with a live audio webcast available on the company's website. The Piper Sandler 32nd Annual Healthcare Conference includes 1-on-1 investor meetings on December 2, 2020, and a pre-recorded fireside chat available from November 23 to December 3, 2020. Otonomy focuses on developing therapeutics for neurotology, addressing significant medical needs.

SAN DIEGO, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that management is scheduled to participate in two upcoming virtual investor conferences.

• Evercore ISI 3rd Annual HealthCONx Conference: presentation on December 1, 2020 at 3:05 p.m. ET / 12:05 p.m. PT. A live audio webcast of the presentation will be available through the Events page of the company’s website at www.otonomy.com and an archived replay will be available shortly after the event.
  
  
• Piper Sandler 32^nd Annual Healthcare Conference: 1 on 1 investor meetings on December 2, 2020. A pre-recorded fireside chat will be accessible from November 23 to December 3, 2020 through the Events page of the company’s website at www.otonomy.com.
  

About Otonomy

Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs including Ménière’s disease, hearing loss, and tinnitus. For additional information please visit www.otonomy.com.

Contacts:

Media Inquiries
Spectrum Science
Chloé-Anne Ramsey
Vice President
404.865.3601
cramsey@spectrumscience.com

Investor Inquiries
Westwicke ICR
Robert H. Uhl
Managing Director
858.356.5932
robert.uhl@westwicke.com  

FAQ

When is Otonomy's presentation at the Evercore ISI 3rd Annual HealthCONx Conference?

Otonomy's presentation is scheduled for December 1, 2020, at 3:05 p.m. ET.

Where can I watch the webcast for Otonomy's conference presentation?

The live audio webcast will be available on Otonomy's website.

What is the date for Otonomy's investor meetings at the Piper Sandler 32nd Annual Healthcare Conference?

The investor meetings are scheduled for December 2, 2020.

How can I access Otonomy's fireside chat at the Piper Sandler conference?

The pre-recorded fireside chat will be accessible from November 23 to December 3, 2020, on Otonomy's website.

What is the main focus of Otonomy as a biopharmaceutical company?

Otonomy is dedicated to developing innovative therapeutics for neurotology, targeting conditions like Ménière’s disease, hearing loss, and tinnitus.